New Delhi: The US & India are working together on COVID-19 therapies and vaccines, and ensuring both countries have access to materials like PPEs and HCQ, said milke Pompeo, US Secretary of State.
Taking to Journalists in a teleconference, Pompeo told TOI, "we (US & INDIA) continues to talk about the bigger issues, free and open Indo-Pacific, challenge of china and trade".
INDIA - US COLLABORATION
The Serum Institute of India has collaborated with NEW YORK - based Codagenis Inc for the purpose of developing a vaccine against the novel coronavirus.
SERUM INSTITUTE OF INDIA
Serum Institute of India Private Limited operates as a biotechnology company. The company produces Polio, Diphtheria, Mumps, and rubella vaccines.
Serum Institute of India serves customers World wide.
The 53 years old company makes 1.5 billion doses every years, mainly from its two facilities in the western city of Pune. (It has two other small plants in the Netherlands and the Czech Republic.) Around 7,000 people work for the firm.
The company supplies some 20 vaccines to 165 countries. Some 80% of its vaccines are exported and, at an average of 50 cents a dose, they are some of the cheapest in the world.
US State SCA says:-
The Economic Times says:-
What will be the price?
COVID-19: Pune company plans to ready 20-40m vaccine short at Rs-1,000/ dose by sept-oct.
India's change to show Soft Power
If all goes well India can showcase its medical powers in front of the world and world on increasing its soft power.
At a time when the world is holding china accountable for coronavirus pandemic, India will emerges as an Asian giant that actually helped the world in this difficult time.
US President Trump thank India
#PROUDMOVEMENTFORINDIA
#COVID19
THANK YOU
Great update
ReplyDeleteIf u have nay query u can ask me any time
DeleteThank you keep supporting
Post a Comment
Of you have any query please ask nad
Thank you for supporting